Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants.
作者信息
Dhawan Manish, Sahni Ashima, Choudhary Om Prakash
机构信息
Department of Microbiology, Punjab Agricultural University, Ludhiana, 141004, Punjab, India.
The Trafford Group of Colleges, Manchester, WA14 5PQ, UK.
出版信息
Ann Med Surg (Lond). 2022 Jan;73:103186. doi: 10.1016/j.amsu.2021.103186. Epub 2021 Dec 23.
Abstract
摘要
相似文献
1
Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants.
Ann Med Surg (Lond). 2022 Jan;73:103186. doi: 10.1016/j.amsu.2021.103186. Epub 2021 Dec 23.
2
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17.
3
Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal.
Vaccines (Basel). 2022 Dec 28;11(1):68. doi: 10.3390/vaccines11010068.
4
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
Expert Rev Vaccines. 2022 Sep;21(9):1177-1184. doi: 10.1080/14760584.2022.2089120. Epub 2022 Jul 1.
5
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020572. doi: 10.1080/21645515.2021.2020572. Epub 2022 Jan 13.
6
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
Vaccine. 2021 Jun 16;39(27):3602-3607. doi: 10.1016/j.vaccine.2021.05.036. Epub 2021 May 18.
7
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2062972. doi: 10.1080/21645515.2022.2062972. Epub 2022 Apr 18.
8
Correlation between Parental Vaccine Hesitancy, Socio-demographic Factors, and Novel SARS-CoV-2 Vaccination in Puerto Rico.
P R Health Sci J. 2022 Dec;41(4):185-191.
9
Explore the reasons for SARS-CoV-2 vaccine hesitancy among healthcare workers: a cross-sectional study.
Ann Med Surg (Lond). 2023 Apr 14;85(6):2443-2450. doi: 10.1097/MS9.0000000000000628. eCollection 2023 Jun.
10
[The determinants of SARS-CoV-2 vaccine hesitancy in a rural area of an Indonesia-Philippines border island: A mixed-method study].
Enferm Clin. 2022 Nov-Dec;32(6):376-384. doi: 10.1016/j.enfcli.2022.02.001. Epub 2022 Mar 3.
引用本文的文献
1
"The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology".
PLOS Glob Public Health. 2024 Dec 20;4(12):e0003023. doi: 10.1371/journal.pgph.0003023. eCollection 2024.
2
Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine.
Sci Rep. 2023 Nov 18;13(1):20213. doi: 10.1038/s41598-023-47611-w.
3
Community dialogue meetings among district leaders improved their willingness to receive COVID-19 vaccines in Western Uganda, May 2021.
BMC Public Health. 2023 May 26;23(1):969. doi: 10.1186/s12889-023-15903-5.
4
Omicron with threatened antagonistic consequences and are convoyed by new fangled risks - Correspondence.
Int J Surg. 2022 Oct;106:106947. doi: 10.1016/j.ijsu.2022.106947. Epub 2022 Sep 22.
5
Clinical Performance of Three Commercial SARS-CoV-2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting.
Front Cell Infect Microbiol. 2022 Jul 5;12:832235. doi: 10.3389/fcimb.2022.832235. eCollection 2022.
6
Vaccine apartheid: the separation of the world's poorest and most vulnerable and the birth of Omicron.
Ther Adv Vaccines Immunother. 2022 Jul 5;10:25151355221107975. doi: 10.1177/25151355221107975. eCollection 2022.
7
COVID-19 Vaccine Uptake in the Context of the First Delta Outbreak in China During the Early Summer of 2021: The Role of Geographical Distance and Vaccine Talk.
Risk Manag Healthc Policy. 2022 Jun 10;15:1203-1214. doi: 10.2147/RMHP.S361024. eCollection 2022.
8
Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions.
Ann Med Surg (Lond). 2022 Jun;78:103737. doi: 10.1016/j.amsu.2022.103737. Epub 2022 May 7.
9
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2068883. doi: 10.1080/21645515.2022.2068883. Epub 2022 May 4.
10
Immunomodulatory effects of zinc and its impact on COVID-19 severity.
Ann Med Surg (Lond). 2022 May;77:103638. doi: 10.1016/j.amsu.2022.103638. Epub 2022 Apr 16.
本文引用的文献
1
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action.
Int J Surg. 2022 Jan;97:106187. doi: 10.1016/j.ijsu.2021.106187. Epub 2021 Dec 9.
2
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
Int J Infect Dis. 2022 Jan;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 1.
3
Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!
J Med Virol. 2022 Apr;94(4):1255-1256. doi: 10.1002/jmv.27491. Epub 2021 Dec 7.
4
COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
Hum Vaccin Immunother. 2021 Oct 3;17(10):3495-3499. doi: 10.1080/21645515.2021.1926183. Epub 2021 Jun 30.
5
Making sound public health policy decisions for COVID-19 vaccination: vaccine effectiveness, safety, affordability, programmatic logistics and roll-out globally.
J Travel Med. 2021 Mar 5. doi: 10.1093/jtm/taab031.
Zotero 插件